Clinical presentation and triggering factors
The classic picture of a gouty attack manifests with sudden acute pain, most commonly affecting a single joint (the knee joint serves as a typical example, although others may be involved). The development of such pain syndrome rarely occurs without an apparent cause; the attack is usually preceded by specific triggers. Among the most frequent provoking factors are exposure to low temperatures (hypothermia) and unusual or intense physical exertion.
Locally in the affected joint area, classic signs of an active inflammatory process are always observed. During the examination, the doctor notes marked hyperemia (redness of the skin) and significant swelling of the surrounding soft tissues. Laboratory blood tests of the patient reveal the key marker of the disease — hyperuricemia, i.e., a pathological increase in uric acid concentration.
Pharmacotherapy: drugs for attack relief
The main objective of treatment in the acute phase is to interrupt the inflammatory cascade as quickly as possible and provide adequate analgesia. To achieve this goal, a strictly defined pool of medications is used:
- Nonsteroidal anti-inflammatory drugs (NSAIDs). They represent the baseline therapy. A typical representative of this group actively used for pain and inflammation relief in gout is ibuprofen.
- Colchicine (Colchicinum). A specific drug successfully used both for the prevention of subsequent gout attacks and for the effective relief of already initiated acute attacks.
- Interleukin-1 blockers. Considered as a possible alternative or additional therapeutic option. A prominent example of a drug from this group is anakinra.
Colchicine pharmacodynamics features
The specific therapeutic effect of Colchicinum is fundamentally different from classic analgesics. Its mechanism of action is based on interference with intracellular processes: the drug targetedly disrupts the normal interaction of $\alpha$- and $\beta$-tubulin molecules. As a result, the cytoskeleton microtubules of the cell are destroyed, making full migration of immune cells into the inflammation focus impossible.
It is important to note the high specificity of colchicine. It is not a universal agent and is not used for treating arthritis of any other etiology. Furthermore, unlike many other anti-inflammatory drugs, the mechanism of action of colchicine is absolutely unrelated to blocking the COX-2 enzyme or affecting macrophage toll-like receptors.
Limitations and common errors in the acute phase
When providing care to a patient with an acute attack, it is necessary to avoid prescribing a number of drugs that may prove useless or even harmful during this period.
Medicines that directly affect uric acid metabolism (e.g., allopurinol) are not intended for analgesia and are not first-line drugs in the acute phase of inflammation. It is also advisable to avoid the use of diuretics (such as hydrochlorothiazide) because they do not help relieve the attack and may be completely contraindicated in an acute gouty attack.
Briefly: answers to topical questions
Which drug classes are used to relieve an acute gout attack?
To relieve an acute gout attack, three main classes of drugs are used, as well as interleukin-1 inhibitors.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) — first-line drugs (e.g., ibuprofen, indomethacin, naproxen, sulindac).
- Glucocorticoids — used systemically or as intra-articular injections.
- Colchicine (colchicine) — a second-line drug that suppresses the acute inflammatory response.
- IL-1 inhibitors — monoclonal antibodies (canakinumab, anakinra) prescribed when core groups are ineffective or contraindicated.
What factors most often provoke the development of an acute gout attack?
Sources indicate the following factors associated with the development of an acute gout attack:
- Dietary factors — alcohol consumption and excess meat intake.
- Physical factors — physical exertion and hypothermia.
- During an acute attack, one should avoid changing the dosage of urate-lowering drugs, as abrupt fluctuations in urate levels can worsen the course of the attack.
Which joint is the most typical target for the first gout attack?
The most typical target for a gout attack is the first metatarsophalangeal joint of the foot. The classic localization of gouty arthritis affects the joints of the feet. Primarily affected is:
- First metatarsophalangeal joint (1st MTP joint) — the articulation between the head of the first metatarsal bone and the base of the proximal phalanx.
Inflammation also frequently affects the ankle joint. Acute microcrystalline inflammation in these areas is accompanied by severe swelling, erythema, and marked pain reaching its maximum within 24 hours.
Which gastrointestinal side effects are most characteristic of colchicine?
The most characteristic gastrointestinal side effects of colchicine are dyspeptic symptoms, especially when taking high oral doses. They include:
- Nausea and vomiting.
- Diarrhea.
- Loss of appetite (anorexia).
In poisoning, early symptoms can mimic gastroenteritis. The clearance of colchicine via the gastrointestinal tract and kidneys is associated with P-glycoprotein.
What is the standard dosing regimen for colchicine to relieve an acute attack?
The standard regimen for relieving an acute gout attack involves using low doses of colchicine. Therapy should be started as early as possible, ideally within the first 12 hours from the onset of the flare. The recommended dosing schedule is:
- First day — a total of 1.5 mg: 1 mg taken at the onset of the flare, then 0.5 mg 1 hour later.
- Subsequent days — 0.5 mg 2–3 times a day, depending on the severity of the arthritis.
To memorize the colchicine target, imagine the internal cellular "TUBE" consisting of two intertwined strands: "Alpha- and Beta-TUBULIN". Colchicine destroys this tube, depriving the cell of mobility.
Class and exam questions
Can allopurinol be used for the emergency relief of acute pain?
No, drugs affecting uric acid metabolism do not possess a direct analgesic effect and are not first-line agents for relieving the acute phase.
Is colchicine suitable for the treatment of rheumatoid or reactive arthritis?
No, colchicine has narrow specificity. It is not a universal agent for arthritis of any etiology and is used predominantly in gout.
Is the anti-inflammatory effect of colchicine related to COX-2 blockade?
No, colchicine does not affect COX-2 and does not interact with macrophage toll receptors. Its action is exclusively due to the destruction of cytoskeleton microtubules.
Which lifestyle factors most commonly trigger a gout attack?
According to the clinical picture, typical provoking factors are intense physical exertion and general or local hypothermia.
What else to study on this topic
- The mechanism of hyperuricemia formation and its effect on joints
- Comparative characteristics of NSAIDs and colchicine in clinical practice
- The role of interleukin-1 in the pathogenesis of gouty inflammation
- The effect of hydrochlorothiazide on uric acid metabolism
- Structure and functions of alpha- and beta-tubulin in immune system cells
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Acute gouty attack" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antigout drugs"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.